Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2025)
Burning Rock Biotech (BNR) recorded quarterly Cash from Investing Activities of -$46000.0 in Q4 2025, up 88.08% quarter-over-quarter from -$386000.0 in Q3 2025, and up 58.56% on a YoY basis from -$29011.4 in Q4 2024.
Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Burning Rock Biotech's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$46000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities rose 58.56% year-over-year to -$46000.0; the TTM figure through Dec 2025 stood at -$828000.0 (up 15.94% YoY), while the FY2025 annual figure was -$628000.0, down 3.97% from the prior year.
- Cash from Investing Activities was -$46000.0 for Q4 2025 at Burning Rock Biotech, up from -$386000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $44.0 million in Q1 2021 to a low of -$11.2 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged $385150.0 across 5 years, with a median of -$358000.0 in 2024.
- The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities soared 8600.12% in 2021, then plunged 496.77% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$10.5 million in 2021, then jumped by 93.05% to -$730000.0 in 2022, then jumped by 93.7% to -$46000.0 in 2023, then plunged by 141.3% to -$111000.0 in 2024, then jumped by 58.56% to -$46000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$46000.0 (Q4 2025), -$386000.0 (Q3 2025), and -$185000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Burning Rock Biotech | 20.35 Mn | -47.48 Mn | 14.10 Mn | -46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | -272,000.00 |
| Sep 30, 2023 | -272,000.00 |